Paula (Pnina) Strauss Levy, Israel

Clinical & Regulatory Drug Development Expert at Strauss-Levy & Co.

Ms. Strauss-Levy has more than 20 years’ experience in the pharma industry, serving as Vice President of clinical, IP and regulatory affairs in global, dually listed (NASDAQ & TASE) pharmaceutical firms. Holds specific expertise in Orphan Drug space, Diabetes T1/2, Respiratory, Oncology, Vaccination and Medical-Cannabis drug development as well as IPO processes and Intellectual property.    

Strauss-Levy & Co. provides clinical development consulting services, clinical management (phases, I-IV & PMS), strategic clinical and regulatory planning (FDA/ EMA/ EU-CA/IMH oriented) and clinical project execution (from early to late development - phases, I-IV & PMS). 

The company provides companies with a unique niche services in the form of interim placement of high rank senior clinical development position members till the optimal employee is tracked-down and thereafter provides further mentoring and guidance to the new employee and company. Strauss-Levy & Co.